Digestive Diseases and Sciences

, Volume 56, Issue 2, pp 323–329 | Cite as

Targeting PI3K/Akt/HSP90 Signaling Sensitizes Gastric Cancer Cells to Deoxycholate-Induced Apoptosis

Original Article

Abstract

Background

The heat shock protein 90 (HSP90) plays a crucial role in the stability of several proteins that are essential for cell survival and for malignant transformation. The binding of HSP90 with pro-survival kinase Akt prevents proteosomal degradation of Akt and contributes to the functional stabilization of PI3K/Akt signaling and cell survival. Akt kinase and HSP90 are therefore highly over-expressed in a large panel of cancer cell lines and are present in multi-chaperoning complexes. In this paper, we investigated whether targeting both Akt and HSP90 would inhibit the survival pathway in AGS cells (human gastric mucosal cells), and how Akt/HSP90 inhibition modulates the deoxycholate (DC)-induced apoptosis.

Methods

AGS cells in the presence of Akt inhibitors (LY294002 and wortmannin), or HSP90 inhibitor (geldanamycin, GA) for 30 min or 18 h, respectively, were treated with DC (50 µM). Activation of PI3K/Akt signaling was evaluated by measuring the Akt and PTEN phosphorylation. HSP90, caspase-3 and caspase-9 were detected in whole lysates by Western blot analysis. AGS cells, transiently transfected with Akt siRNA, were treated with DC, and apoptosis was measured by caspase-3 activation. Apoptotic-positive cells were counted according to changes of cell morphology by Hoechst staining and fluorescence microscopy.

Results

The intrinsic level of phospho-Akt (pAkt; active form), phospho-PTEN (pPTEN; inactive enzyme) and HSP90 were highly expressed in AGS cells indicating the active PI3K/Akt/HSP90 signaling. Although, deoxycholate at low concentration (50 µM) slightly inhibited the expression of pAkt and cleaved HSP90 to 55 KDa fragment, no significant effect on apoptosis induction, up to 4 h (as assessed by caspase-3 activation) was observed. The higher concentrations of DC (100 µM-300 µM) resulted in progressive inhibition of pAkt, activation of PTEN, and specific cleavage of HSP90 to approximately 45 KDa fragments with significant induction of apoptosis. Although DC (50 µM) had no profound effect on Akt/HSP90 and did not induce apoptosis, it became an inducer of apoptosis when cells were pretreated with LY294002, wortmannin, or geldanamycin. Consistent with these findings, significant activation of apoptosis in response to DC (50 µM) was observed in cells with depleted Akt protein.

Conclusions

These results demonstrate that down-regulation of PI3K/Akt pathway with specific cleavage of HSP90 to 45 KDa modulates the pro-apoptotic effects of DC in gastric cells. They further indicate the importance of stable Akt/HSP90 complex in regulation of survival/death responses.

Keywords

Cell signaling Heat shock proteins Apoptosis AGS cell line 

Notes

Acknowledgments

These studies were supported by The Jeffress Memorial Trust grant J-878 awarded to Dr. Maria J. Redlak.

References

  1. 1.
    Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase-Akt pathway in human cancer. Nature Rev Cancer. 2002;2:489–501.CrossRefGoogle Scholar
  2. 2.
    Michl P, Downward J. Mechanism of disease: PI3K/AKT signaling in gastrointestinal cancers. Gastroenterology. 2005;43(10):1133–1139.Google Scholar
  3. 3.
    Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3/Akt pathway in cell cycle progression, apoptosis and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003;17:590–603.CrossRefPubMedGoogle Scholar
  4. 4.
    Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev. 1999;13:2905–2927.CrossRefPubMedGoogle Scholar
  5. 5.
    Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinosil 3-kinase activation. J Neurochem. 2003;87:1427–1435.CrossRefPubMedGoogle Scholar
  6. 6.
    Meier L, Alessi DR, Cron P, Andjelkovic M, Hemmings BA. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bβ. J Biol Chem. 1997;272:30491–30497.CrossRefPubMedGoogle Scholar
  7. 7.
    Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J. 2000;346:561–576.CrossRefPubMedGoogle Scholar
  8. 8.
    Maehama T. PTEN: its deregulation and tumorigenesis. Biol Pharm Bull. 2007;30(9):1624–1627.CrossRefPubMedGoogle Scholar
  9. 9.
    Wegele H, Muller L, Buchner J. Hsp70 and Hsp90—a relay team for protein folding. Rev Physiol Biochem Pharmacol. 2004;151:1–44.CrossRefPubMedGoogle Scholar
  10. 10.
    Neckers L. HSP90 inhibitor as novel cancer chemotherapeutic agent. Trends Mol Med. 2002;8(4):S55–S61.CrossRefPubMedGoogle Scholar
  11. 11.
    Kamal A, Thao L, Sensintaffar J, et al. A high-affinity conformation of HSP90 confers tumor selectivity on HSP90 inhibitors. Nature. 2003;425:407–410.CrossRefPubMedGoogle Scholar
  12. 12.
    Isaacs JS, Xu W, Necker L. Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell. 2003;3:213–217.CrossRefPubMedGoogle Scholar
  13. 13.
    Redlak MJ, Dennis MS, Miller TA. Apoptosis is a major mechanism of deoxycholate-induced gastric mucosal cell death. Am J Physiol Gastrointest Liver Physiol. 2003;25(5):G870–G879.Google Scholar
  14. 14.
    Redlak MJ, Power JJ, Miller TA. Protein kinase C involvement in deoxycholate-induced apoptosis in human gastric cells. Dig Dis Sci. 2006;51(5):834–843.CrossRefPubMedGoogle Scholar
  15. 15.
    Redlak MJ, Power JJ, Miller TA. Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kB and PKC signaling. J Surg Res. 2008;145:66–73.CrossRefPubMedGoogle Scholar
  16. 16.
    Bradford HW. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.CrossRefPubMedGoogle Scholar
  17. 17.
    Jeon YK, Park CH, Kim K-Y, et al. The heat-shock protein 90- inhibitor, geldanamycin induces apoptosis cell death in Epstein-Barr virus-positive NK/T-cell lymphoma by Akt down-regulation. J Pathol. 2007;213:170–179.CrossRefPubMedGoogle Scholar
  18. 18.
    Chandarlapaty S, Sawai A, Ye Q, et al. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clin Cancer Res. 2008;14(1):240–248.CrossRefPubMedGoogle Scholar
  19. 19.
    Moser C, Lang SA, Stoeltzing O. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer. Anticancer Res. 2009;29:2031–2042.PubMedGoogle Scholar
  20. 20.
    Arya R, Malik M, Lakhotia SC. Heat shock genes—integrating cell survival and death. J Biosci. 2007;32:595–610.CrossRefPubMedGoogle Scholar
  21. 21.
    Pandey P, Saleh A, Nakazawa A, et al. Negative regulation of cytochrom c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 2000;19:4310–4322.CrossRefPubMedGoogle Scholar
  22. 22.
    Zhao C, Wang E. Heat shock protein 90 suppresses tumor necrosis factor alpha induced apoptosis by preventing the cleavage of Bid in NIH3T3 fibroblasts. Cell Signal. 2004;16:313–321.CrossRefPubMedGoogle Scholar
  23. 23.
    Beck R, Varrax J, Gonze T, et al. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death. Biochem Pharmacol. 2009;77(3):375–383.CrossRefPubMedGoogle Scholar
  24. 24.
    Pantano C, Shrivastava P, McElhinney B, Janssen-Heininger Y. Hydrogen peroxide signaling through tumor necrosis factor receptor 1 leads to selective activation of c-Jun N-terminal kinase. J Biol Chem. 2003;278:44091–44096.CrossRefPubMedGoogle Scholar
  25. 25.
    Panopoulos A, Harraz M, Engelhardt JF, Zandi E. Iron-mediated H2O2 production as a mechanism for cell type-specific inhibition of tumor necrosis factor alpha-induced but not interleukin-1beta-indiced IkappaB kinase complex/nuclear factor-kappaB activation. J Biol Chem. 2005;280:2912–2923.CrossRefPubMedGoogle Scholar
  26. 26.
    Chen H, Xia Y, Fang D, Hawke D, Lu Z. Caspase-10 mediated heat shock protein 90B cleavage promotes UVB irradiation-induced cell apoptosis. Mol Cell Biol. 2009;29(13):3657–3664.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of SurgeryMedical College of Virginia Commonwealth UniversityRichmondUSA

Personalised recommendations